The most common concentrations include 2.5mg/mL (typically in smaller 1 mL vials containing 2.5 mg total), 5mg/mL (in 1 mL vials containing 5 mg total or 2 mL vials containing 10 mg total), and occasionally higher concentrations for patients on maintenance doses
Adverse reactions led to treatment discontinuation in 6.8% of patients treated with WEGOVY 25 mg tablet and 5.9% patients receiving placebo
In another 56-week clinical trial, people taking Saxenda 3 mg once a day lost an average of 18 lbs, while those using a placebo injection only lost 8 lbs
But we need to strike a balance between these (and other) risks and the benefits of GLP-1 medications in diabetes care, obesity treatment, reducing heart attack risks and extending lives
These medications were first made to help with type 2 diabetes, but now some of them are also approved by the FDA to help with weight loss
In clinical trials of Ozempic and Wegovy, nausea was reported in: 15.8% of people taking a 0.5 milligram (mg) dose 20.3% of people taking a 1 mg dose 44% of people taking a 2.4 mg dose Nausea is a common side effect of semaglutide, but its also seen with other similar medications in the GLP-1 receptor agonist class
